- Home
- UBX vs FTHM Comparison
UBX vs FTHM Comparison
Compare UBX & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- FTHM
- Stock Information
- Founded
- UBX 2009
- FTHM 2010
- Country
- UBX United States
- FTHM United States
- Employees
- UBX N/A
- FTHM N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- FTHM Real Estate
- Sector
- UBX Health Care
- FTHM Finance
- Exchange
- UBX Nasdaq
- FTHM Nasdaq
- Market Cap
- UBX 29.2M
- FTHM 32.8M
- IPO Year
- UBX 2018
- FTHM 2020
- Fundamental
- Price
- UBX $2.22
- FTHM $1.25
- Analyst Decision
- UBX Strong Buy
- FTHM Strong Buy
- Analyst Count
- UBX 2
- FTHM 4
- Target Price
- UBX $7.00
- FTHM $4.25
- AVG Volume (30 Days)
- UBX 483.8K
- FTHM 96.8K
- Earning Date
- UBX 11-04-2024
- FTHM 03-13-2025
- Dividend Yield
- UBX N/A
- FTHM N/A
- EPS Growth
- UBX N/A
- FTHM N/A
- EPS
- UBX N/A
- FTHM N/A
- Revenue
- UBX N/A
- FTHM $317,515,000.00
- Revenue This Year
- UBX N/A
- FTHM N/A
- Revenue Next Year
- UBX $33.62
- FTHM $28.50
- P/E Ratio
- UBX N/A
- FTHM N/A
- Revenue Growth
- UBX N/A
- FTHM N/A
- 52 Week Low
- UBX $0.94
- FTHM $1.19
- 52 Week High
- UBX $3.10
- FTHM $3.37
- Technical
- Relative Strength Index (RSI)
- UBX 61.12
- FTHM 34.42
- Support Level
- UBX $2.02
- FTHM $1.25
- Resistance Level
- UBX $2.42
- FTHM $1.48
- Average True Range (ATR)
- UBX 0.31
- FTHM 0.11
- MACD
- UBX 0.01
- FTHM 0.00
- Stochastic Oscillator
- UBX 39.61
- FTHM 13.33
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title.